Xcout IntelTizona Therapeutics competitors & alternatives
The 12 closest competitors and alternatives to Tizona Therapeutics among biotechnology companies — ranked by similarity to what Tizona Therapeutics actually does, not by market-cap band.
Subscribe to see Tizona Therapeutics’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Tizona Therapeutics
Tizona Therapeutics, Inc. is a privately held immunology company founded in 2015 and headquartered in South San Francisco, California. The company focuses on harnessing the power of the immune system to develop treatments.
Tizona Therapeutics at a glance
Tizona Therapeutics is a biotechnology company headquartered in United States, founded in 2015. Its most recent funding round, Series B, raised $43M in March 2016. Xcout tracks 8 named people at Tizona Therapeutics, including Christine O Brien (Chief Executive Officer).
Tizona Therapeutics leadership
- Christine O BrienChief Executive Officer
- Courtney BeersChief Scientific Officer
- Robert Ilaria, Jr., MDChief Medical Officer
- Erin JohnsonSenior Vice President, Program Leadership and Alliance Management
- Dan SpiegelmanChair, Tizona Therapeutics Director, Myriad Genetics, Inc. Former EVP & CFO, BioMarin Pharmaceutical Inc.
- Kurt Von EmsterManaging Partner, Abingworth
2 more named people on record for Tizona Therapeutics, with roles, board committees and tenure — see the full roster →
Tizona Therapeutics funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $43M | 4 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Top 12 Tizona Therapeutics competitors
Ranked by semantic similarity — how close each company is to Tizona Therapeutics by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar biotechnology company
Ouro Medicines is a biotechnology company headquartered in South San Francisco, California, developing immune reset therapeutics for chronic immune-mediated diseases.
Similar biotechnology company
RAPT Therapeutics is a clinical-stage biopharmaceutical company headquartered in South San Francisco, California. Founded in 2015, the public company leverages its proprietary drug discovery platform to develop treatments for inflammatory and immunologic diseases.
Biotech
TRex Bio, Inc. is a clinical-stage biotechnology company headquartered in South San Francisco, California. The company focuses on discovering and developing precision therapeutics to treat moderate-to-severe immune-mediated diseases by targeting regulatory T cells.
Similar biotechnology company
Sift Biosciences is a privately held biotechnology company founded in 2024 and headquartered in San Carlos, California. The company is focused on harnessing pre-existing hidden immunity.
Similar biotechnology company
Immune Design Corp. is a clinical-stage immunotherapy company with offices in Seattle, Washington, and South San Francisco, California, specializing in novel drug discovery and treatment technologies.
Biotech
Dualitas Therapeutics is a privately held biotechnology research company headquartered in South San Francisco, California, that utilizes its DualScreen Bispecific Discovery Engine for proximity engagers.
Similar biotechnology company
Immunitas Therapeutics, Inc. is a US-based biotechnology company established in 2019 and headquartered in Waltham, Massachusetts. The company focuses on pioneering novel therapeutic treatments in immunology and oncology.
Similar biotechnology company
Amphivena Therapeutics, Inc. is a privately held, clinical-stage biotechnology company based in South San Francisco, California. The company specializes in immuno-oncology, developing a platform of dual-function biologics and selective T cell engagers for the treatment of hematological conditions.
Similar biotechnology company
Centivax is a privately held, clinical-stage biotechnology company headquartered in South San Francisco, California. The company focuses on accelerating the transition to a post-pathogen world by developing broad-spectrum vaccines, COVID-19 therapeutics, and antivenom antibodies.
Similar biotechnology company
IgGenix is a clinical-stage, venture-backed biotechnology company founded in 2019 and headquartered in South San Francisco, California. The company leverages its proprietary antibody discovery platform with a primary mission to cure allergies and other immunological diseases.
Health & Life Sciences
Deciduous Therapeutics, Inc. is a biotechnology startup located in San Francisco, California, focused on developing novel therapeutics targeting aging and immune dysfunction.
Similar biotechnology company
Sundance Biosciences is a biotechnology company founded in 2025 and headquartered in South San Francisco, California. The firm focuses on developing oral therapies that selectively target TYK2 to modulate immune responses for treating complex diseases.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Tizona Therapeutics and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Tizona Therapeuticsand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →